CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
PASS LP implants +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04670536
NCT04670536N/ACompleted

The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems.

Medicrea International·observational·Posted Dec 17, 2020·Updated May 1, 2026

In Brief

An observational study evaluating PASS LP implants, PASS DEGEN, and 1 other intervention for Thoracolumbar Disc Degeneration and 3 related conditions. Completed, enrolled 77 participants across 4 sites.

Detailed Summary

The purpose of this post-market clinical study is to evaluate the long-term safety and efficacy of the MEDICREA's systems PASS LP, PASS DEGEN, and PASS Tulip PRIME to treat degenerative diseases. This study is supporting the clinical evaluation report. From the standard-of-care perspective, the results of The Degen study are expected to contribute to a better understanding of expected safety and clinical outcomes from a short (intra- and peri-operative) to a medium-term follow-up (post-operatively).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 17, 2020
Enrollment StartMay 17, 2018
Primary CompletionMay 22, 2024
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 5.5 years ago

Interventions

PASS LP implantsdevice

Thoraco lumbar arthrodesis

PASS DEGENdevice

Thoraco lumbar arthrodesis

PASS TULIP PRIMEdevice

Thoraco lumbar arthrodesis